Lucid Diagnostics LUCD Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.26M+51.7% | $1.5M+25.6% | $1.21M+3.3% | $1.16M+19.2% | $828K-17.3% | ||
| $1.63M+4.8% | —— | —— | —— | $1.55M-12.6% | ||
| $1.21M-15.5% | $1.72M+18.6% | $1.27M-23.6% | $1.26M-8.5% | $1.43M-4.9% | ||
| $5M+22.9% | $5.34M+33.4% | $4.29M+5.8% | $4.01M-4.8% | $4.07M-3.0% | ||
| $5.43M-11.8% | $6.48M+10.6% | $5.61M+4.7% | $5.62M+15.4% | $6.16M+51.4% | ||
| $13.37M+0.4% | —— | —— | —— | $13.32M+5.7% | ||
| -$12.11M+3.0% | -$14.01M-13.2% | -$11.76M-0.6% | -$11.38M-1.7% | -$12.49M-15.7% | ||
| -964.5%+544pp | -931.6%+102pp | -971%+26.8pp | -978.8%+168pp | -1,508.1%-430pp | ||
| $6K-33.3% | $6K-14.3% | $2K+100% | $6K0.0% | $9K-25.0% | ||
| -$1.8M+87.6% | -$2.26M-370% | $1.36M+301% | $6.95M+3,614% | -$14.42M-8,112% | ||
| -$13.91M+48.3% | -$16.27M-40.9% | -$10.4M+16.0% | -$4.44M+59.7% | -$26.91M-154% | ||
| $0— | —— | —— | —— | $0— | ||
| -$13.91M+48.3% | -$16.27M-40.9% | -$10.4M+16.0% | -$4.44M+59.7% | -$26.91M-154% | ||
| -1,107.4%+2,142pp | -1,081.5%-117pp | -858.5%+197pp | -381.7%+746pp | -3,249.8%-2,190pp | ||
| -$11.89M+3.0% | -$13.8M-13.6% | -$11.54M-0.5% | -$11.16M-1.8% | -$12.27M-19.2% | ||
| -946.8%+535pp | -917.7%+97.6pp | -952.8%+26.6pp | -959.8%+163pp | -1,481.4%-453pp | ||
| -$12.11M+3.0% | -$14.01M-13.2% | -$11.76M-0.6% | -$11.38M-1.7% | -$12.49M-15.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Lucid Diagnostics's revenue?
- Lucid Diagnostics (LUCD) generated $5.1M in revenue over the trailing twelve months, up 23.0% year over year.
- Is Lucid Diagnostics profitable?
- Lucid Diagnostics is not currently profitable: it reported a net loss of $45.0M over the trailing twelve months, a -876.7% net margin.
- What are Lucid Diagnostics's profit margins?
- Gross margin is -66.8% and operating margin is -959.6%, with a -876.7% net margin.
- Where does Lucid Diagnostics's income statement data come from?
- Every line is extracted from Lucid Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
